A carregar...

Circulating Biomarkers of Response to Sunitinib in Gastroenteropancreatic Neuroendocrine Tumors: Current Data and Clinical Outlook

After years of limited progress in the treatment of patients with advanced-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs), strategies using targeted agents have been developed on the basis of increased knowledge of the biology of these tumors. Some of these agents, targeting vascular...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mateo, Joaquin, Heymach, John V., Zurita, Amado J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3872147/
https://ncbi.nlm.nih.gov/pubmed/22515658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11632590-000000000-00000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!